NCT03612817View on ClinicalTrials.gov

Preservative-free Tafluprost/Timolol Fixed Combination: Morning vs Evening Dosing

PHASE4CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

April 30, 2018

Study Completion Date

July 31, 2018

Conditions
Glaucoma, Open-Angle
Interventions
DRUG

Tafluprost/timolol fixed combination

Evaluation of 24-hour pressure control with tafluprost/timolol given in the evening or morning

Trial Locations (1)

54636

1st University Department of Ophthalmology, Thessaloniki

All Listed Sponsors
collaborator

Santen Oy

INDUSTRY

lead

Aristotle University Of Thessaloniki

OTHER

NCT03612817 - Preservative-free Tafluprost/Timolol Fixed Combination: Morning vs Evening Dosing | Biotech Hunter | Biotech Hunter